2BB score and signals
Nurix Therapeutics, Inc.’s current 2BB score is 41 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|
| Activity | 65 | High |
| Momentum | 51 | Stable |
| Financial strength | 20 | Very Weak |
| Quality | 100 | Very Strong |
| Risk | 40 | Low |
Company facts
| Headquarters | Brisbane, California, United States |
| Founded | 2009 |
| Employees | 317 |
| 52-week range | $8.20 – $26.82 |
Recent earnings
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|
| 2027-01-26 | — | -0.5006 | — | $28.74M |
| 2026-10-07 | — | -0.5891 | — | $22.77M |
| 2026-07-09 | -0.81 | -0.7312 | $9.04M | $16.49M |
| 2026-04-08 | -0.79 | -0.7694 | $6.25M | $15.99M |
Related companies
